Has Foster Lasley, MD received payments from drug or device companies?

Yes. Drug and device makers reported $8,145 in general payments to Foster Lasley, MD across 456 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Foster Lasley, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Foster Lasley, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Foster Lasley, MD

Radiation Oncology · Fayetteville, ARNPI 1407083058

Payments from drug & device makers

$8,145in general payments, 2019–2025

Across 456 payments — averaging $17.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Merck$770
Novartis$739
Eisai Inc.$575
Regeneron Healthcare Solutions, Inc.$464
Amgen$389
Beigene USA, Inc.$348
plus $5K from 53 others

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Merck	45	$770
Novartis	41	$739
Eisai Inc.	26	$575
Regeneron Healthcare Solutions, Inc.	21	$464
Amgen	23	$389
Beigene USA, Inc.	24	$348
Bristol Myers Squibb	21	$345
AstraZeneca	14	$287
Puma Biotechnology, Inc.	19	$282
Johnson & Johnson	17	$277
Bayer	16	$246
Exelixis Inc.	15	$235
Rigel Pharmaceuticals, Inc.	12	$213
Daiichi Sankyo Inc.	12	$210
Sanofi	10	$176
Seagen Inc.	10	$150
Coherus Oncology, Inc.	9	$146
Lilly USA, LLC	9	$141
Incyte Corporation	9	$139
Takeda Pharmaceuticals U.S.A., Inc.	7	$118
Pharmacyclics LLC, An Abbvie Company	5	$118
Sirtex Medical Inc	1	$104
Karyopharm Therapeutics Inc.	6	$103
Sobi, Inc	5	$99
Dendreon Pharmaceuticals LLC	4	$97
Clovis Oncology, Inc.	7	$90
Ipsen Biopharmaceuticals, Inc	5	$87
Myriad Genetic Laboratories, Inc.	4	$80
Elekta, Inc.	1	$73
AbbVie	4	$70
Myovant Sciences Inc.	3	$65
AVEO Pharmaceuticals, Inc.	3	$64
Sun Pharmaceutical Industries Inc.	4	$60
Stemline Therapeutics Inc.	3	$57
Spectrum Pharmaceuticals Inc.	3	$51
Pfizer	3	$48
Astellas Pharma US Inc	2	$42
Blue Earth Diagnostics	1	$40
G1 Therapeutics, Inc.	3	$39
Menarini Silicon Biosystems, Inc.	1	$36
Boehringer Ingelheim	2	$36
Kyowa Kirin, Inc.	2	$35
Morphosys, US Inc.	2	$34
Genentech USA, Inc.	2	$34
CTI Biopharma Corp.	2	$33
Taiho Oncology, Inc.	2	$31
Iovance Biotherapeutics, Inc.	2	$31
Fortovia Therapeutics, Inc.	2	$30
EMD Serono, Inc.	2	$28
Progenics Pharmaceuticals, Inc.	1	$27
Novocure Inc.	1	$25
Boston Scientific	1	$19
Mirati Therapeutics, Inc.	1	$19
Syndax Pharmaceuticals, Inc.	1	$17
Jazz Pharmaceuticals Inc.	1	$16
Caris MPI, Inc.	1	$15
ADC Therapeutics America, Inc.	1	$14
Pharmaessentia USA Corporation	1	$13
Pharmacosmos Therapeutics Inc.	1	$13

How this compares

$8,145 in reported general payments places this provider in the 95th percentile of 45 radiation oncology providers in Arkansas.

See all radiation oncology providers in Arkansas →

Medicare billing

Part B allowed, 2024

$1,473,258

Medicare patients

472

Services billed

6,741

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other radiation oncology in Fayetteville

Chris McClintonFayetteville$4K
Wesley GarnerFayetteville$3K
Arnold SmithFayetteville$3K
Hershel GarnerFayetteville$2K
Matthew MalloryFayetteville$898
Joshua AndersonFayetteville$98
Joseph RossFayetteville$61
Scarlett Acklin-WehnertFayetteville$14
Santanu SamantaNorth Little Rock$34K
Matthew McKeeverFort Smith$5K

See the full list for Arkansas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →